Examkin

Question

Difficulty: MediumPediatric Respiratory Disorders

An 8-year-old boy arrives at the pediatric emergency department via emergency medical services with severe difficulty breathing. The symptoms began abruptly while he was playing outdoors in cold weather. He has a documented history of moderate persistent asthma. En route to the hospital, paramedics administered three back-to-back doses of nebulized albuterol and ipratropium, as well as one dose of intramuscular epinephrine, with minimal clinical improvement.

On arrival, the patient appears visibly exhausted, diaphoretic, and is leaning forward in a tripod position. He is only able to speak in single words. Vital signs are temperature 37.0°C (98.6°F), heart rate 160/min, respiratory rate 48/min, and oxygen saturation 89% on a non-rebreather mask. Physical examination reveals severe suprasternal and subcostal retractions. Lung auscultation demonstrates a 'silent chest' with markedly diminished air entry bilaterally and no audible wheezing. A portable chest radiograph shows bilateral hyperinflation but no focal consolidations or pneumothorax.

Which of the following are the most appropriate immediate steps in the management of this patient? (Select all that apply)

  1. Intravenous administration of magnesium sulfateAnswer
  2. Intravenous administration of methylprednisoloneAnswer
  3. Initiation of noninvasive positive pressure ventilationAnswer
  4. D
    Intravenous administration of a broad-spectrum cephalosporin
  5. E
    Intravenous administration of furosemide

Answer

The correct immediate steps are the intravenous administration of magnesium sulfate, intravenous administration of methylprednisolone, and the initiation of noninvasive positive pressure ventilation.
This patient is presenting with severe status asthmaticus progressing to impending respiratory failure, characterized by a 'silent chest' (due to critically low airflow), hypoxia despite supplemental oxygen, and clinical exhaustion. Management of life-threatening asthma requires a multi-pronged approach. First, advanced airway support, such as noninvasive positive pressure ventilation (NPPV), must be initiated to reduce the patient's work of breathing and prevent hypercapnic respiratory arrest. Simultaneously, maximum pharmacological escalation is necessary because he has already failed initial bronchodilators (albuterol, ipratropium) and IM epinephrine. Intravenous magnesium sulfate acts as a potent smooth muscle relaxant to aid in bronchodilation. Intravenous methylprednisolone is required to rapidly address the underlying severe airway inflammation. Oral corticosteroids are generally avoided in impending respiratory failure due to the risk of aspiration or inability to swallow safely.

Step-by-Step Solution

1
Assess the severity of the patient's respiratory status based on the clinical presentation and physical examination.
The patient has a 'silent chest', hypoxia (89% on high-flow oxygen), exhaustion, and inability to speak in sentences, indicating severe status asthmaticus with impending respiratory failure.
Accurate assessment of asthma severity dictates the necessary level of intervention and urgency of airway support.
2
Determine the appropriate pharmacological step-up therapy for a patient failing continuous inhaled bronchodilators and intramuscular epinephrine.
Intravenous magnesium sulfate and intravenous systemic corticosteroids (methylprednisolone) are indicated to provide aggressive bronchodilation and reduce airway inflammation.
Standard asthma pathways require escalating to systemic adjuncts when initial therapy fails to reverse severe bronchospasm.
3
Identify the need for advanced airway support.
Initiation of noninvasive positive pressure ventilation (NPPV) is required to support the patient's work of breathing while pharmacological therapies take effect.
Exhaustion and a silent chest suggest the patient cannot maintain adequate ventilation on their own, risking hypercapnic respiratory arrest.

Key Concept

The management of severe status asthmaticus with impending respiratory failure requires concurrent aggressive pharmacological escalation (IV magnesium sulfate, IV corticosteroids) and immediate airway support (NPPV or intubation).
Rate this question

Topics

Pediatric Respiratory Disorders

More questions from this topic